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Breast cancer
Dear Editor
I have just read the publication Guidelines for preventive 
activities in general practice . It is, as one would 
expect, excellent. I wish to comment on one area – 8.4 
Breast cancer:
 1.  ‘Clinical breast examination is not recommended 
as a routine for women undergoing regular 
mammographic screening’. 
As in many areas of our society today, there is a 
clear implication here that tests are infallible – they 
are not. Breast lumps can also develop in between 
mammograms. An occasional one of these is malignant, 
and very occasionally, can be detected clinically.
 2.  ‘All women should be advised to be aware of the 
normal look and feel of their breasts and to report 
any new or unusual changes to their GP without 
delay. There is no evidence that teaching women 
to undertake regular breast self examination is 
effective’.
I have difficulty in reconciling these two statements. If 
the second is true, why is the first one made? Although 
all the evidence I have seen does seem to dispute the 
effectiveness of BSE, my experience is that a significant 
proportion of breast cancers I have seen were brought to 
my attention by the patient’s presenting complaint: ‘I’ve 
found a lump in my breast’.
 As an aside, I have found many more breast and 
thyroid lumps, skin lesions needing removal, blood 
pressure problems, and family problems in response 
to the question: ‘And how are things going in general?’ 
than abnormal smears when doing routine Pap tests 
according to the protocol. Perhaps holistic, patient 




1. There is lack of evidence for clinical breast examination 
as a screening measure in itself and or for its use as 
an alternative to mammography. There is evidence 
for mammography. Women screened with mammography 
have lower risk than those who have not. So CBE is 
even less indicated as a screening tool in this population 
group. This is the justification for not recommending 
CBE. It is not saying that mammography is infallible. 
If a women who has had a negative mammogram 
presents with a lump she should be investigated 
with fine needle biopsy.
 2. The second point is more difficult to explain. There 
is insufficient evidence to support teaching women 
BSE as part of a population prevention program. This is 
because women taught BSE are no more likely to detect 
breast cancers than those who are simply advised to ‘be 
aware of the normal look and feel of their breasts and 
report any new or unusual changes to the GP without 
delay’. This might seem counter intuitive but it is what 
the trials indicate.
Mark Harris
RACGP Red Book Task Force
Uptake of spirometry training by GPs
Dear Editor
The majority of patients with chronic respiratory 
symptoms initially present themselves to their GP.1 
Spirometry is the recommended tool for objectively 
diagnosing and monitoring asthma in general practice 
because of its consistency and reproducibility. However, 
adequate training and education is imperative if 
GPs are to competently perform spirometry and 
interpret results.2 Little is known about the attitudes of 
GPs toward  sp i rometr y  t ra in ing 3 and  fac tors 
influencing participation.
 We have been conducting a cluster randomised 
controlled trial in South Australia and New South Wales, 
with 40 practices and 560 patients participating. Half 
of the practices were randomised into an intervention 
group where practitioners and staff were educated about 
their roles in systematic care, spirometry and the Asthma 
3+ Plan. Fifty-nine GPs were invited to participate in 
a spirometry training workshop, but only five (8.5%) 
attended. In order to understand reasons for or against 
their attendance, a postworkshop questionnaire was sent 
to the GPs, which resulted in 50 (84.7%) responses. 
 The primary driver for those GPs who did attend 
the workshop was the expectation of gaining a more 
comprehensive understanding of spirometry results. 
By contrast, a heavy workload and l imited time 
constraints were the most frequently reported reasons 
for nonattendance (n=22, 44%). Other reasons were 
less frequent: five GPs (10%) felt the training would not 
be of benefit to themselves or their patients; six (12%) 
lacked spirometers; four (8%) GPs were discouraged 
as no CPD points were available, and four (8%) had 
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recently trained in spirometry. By contrast, 11 
(22%) GPs reported they had plans to attend 
spirometry training in the near future although 
they did not provide specific details. 
 It is evident that if spirometry is to be 
promoted in primary care, education programs 
must be offered that meet the needs of GPs 
and address the barriers to their attendance. 
Relevant educational material should be made 
available before the program and the training 
provided through in-practice workshops, or 
perhaps by on-line or distance learning modes. 
We also need to clarify whether other staff 
members should complete this training, if 
GPs have no time. CPD points are important 
to GPs, but they also need to be convinced 
(with appropriate evidence gathered from 
primary care) that spirometry will make a 
difference to patient care and that it is cost 
effective to purchase a machine and perform 
spirometry regularly.
Justin Beilby, University of Adelaide, SA
Clare Harper, University of New South Wales
Christine Holton, University of Adelaide, SA
Judy Proudfoot, University of New South 
Wales
Mark Harris, University of New South Wales
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Clinical teaching 
Dear Editor
I enjoyed reading the article on clinical teaching 
by Professor Molodysky and colleagues (AFP 
January/February 2006).
 The authors state that academic leaders 
rarely expect cl in ical  teachers to have 
undergone formal or even informal training 
for this vocation. In fact the academic leaders 
seldom value or reward those who are 
good at clinical teaching. Most Australian 
universit ies appoint and promote their 
academic staff for their research work; even 
here the preference is for basic research, ie. 
clinical and teaching skills are largely irrelevant 
in their system of meritocracy.
 I hope the insightful article and the proposal 
therein for new directions in clinical training 
will encourage at least some ‘leaders’ to 
review their current system.
A Manoharan
Sydney, NSW
Fetal alcohol syndrome 
Dear Editor 
We read with interest the excellent articles on 
growth and developmental delay in children 
and adolescents (AFP September 2005). We 
were disappointed to discover however, that 
alcohol exposure during pregnancy was not 
discussed as a cause of growth failure and 
developmental delay.
 Alcohol is a teratogen that can have a 
devastating effect on the developing fetus. The 
extreme manifestation of exposure to alcohol 
in utero is fetal alcohol syndrome (FAS), a 
composite of pre- and/or post-natal growth 
retardation, characteristic facial features, 
and structural defects and/or dysfunction of 
the central nervous system.1 It is also well 
recognised that the child exposed to alcohol in 
utero may present with a wide range of other 
birth defects, or developmental, psychological, 
cognitive and behavioural problems in the 
absence of structural birth defects. This had 
led to the introduction of a more inclusive 
term ‘fetal alcohol spectrum disorder’ (FASD), 
which is now used to include children with 
FAS, alcohol related neuro-developmental 
disorders, and alcohol related birth defects. 
Although FASD is entirely preventable,2 our 
research suggests that some Australian 
families have more than one affected child, 
and that opportunities for prevention have 
been missed.3
 Our research also suggests that FAS is 
under-recognised in Australia. This may be due 
to lack of routine screening of pregnant women 
and women of childbearing age for evidence of 
alcohol use, and/or to health professionals’ 
lack of knowledge about and hence ability 
to diagnose FAS.
 The December issue of the Australian 
and New Zealand Journal of Public Health4 
contains the results of a survey investigating 
the knowledge and practices of health 
professionals regarding FAS and alcohol use 
during pregnancy. Fewer than half of the health 
professionals surveyed routinely took a history 
of alcohol use in pregnant patients; only a 
quarter routinely provided information on the 
possible harm to the fetus from alcohol; few 
had diagnosed FAS; and 98% felt ill prepared 
to deal with a child with FAS. The results of 
our recent survey of WA paediatricians were 
similar. There is an urgent need for education 
of health professionals to address these gaps 
in knowledge and practice thereby improving 
prevention and diagnosis of FAS. 
 We strongly support the commissioning 
of articles on alcohol use during pregnancy 
and FASD to help address knowledge gaps in 
Australia’s family physicians.
C O’Leary, C Bower, J Payne, University of WA
E Elliott, University of Sydney, NSW
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